Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07447713 · ClinicalTrials.gov registry record
Reference Range Study for the Quantra System With the QPlus Cartridge in Pediatric Patients
A clinical trial, sponsored by HemoSonics.
- Not yet
- Registry status
- 240
- Enrollment target
NCT07447713 is a clinical trial that has not yet begun recruiting, run by HemoSonics. The registered enrollment target is 240 participants.
The verdict
NCT07447713 has not yet begun recruiting, sponsored by HemoSonics.
- NOT YET RECRUITING
- Registry status
- 240 participants
- Enrollment target
Study Summary
This study will determine reference range intervals for the parameters reported by the Quantra System with the QPlus Cartridge in pediatric patients.
Interventions
- DIAGNOSTIC_TEST Quantra System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2026-04-15 |
| Est. Completion | 2027-05-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07447713
The ClinicalTrials.gov registry entry for NCT07447713 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HemoSonics, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quantra System is the first listed.
NCT07447713 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07447713 about?
NCT07447713 is a clinical study titled "Reference Range Study for the Quantra System With the QPlus Cartridge in Pediatric Patients". This study will determine reference range intervals for the parameters reported by the Quantra System with the QPlus Cartridge in pediatric patients.
What is the current status of trial NCT07447713?
This trial is currently not yet recruiting. The enrollment target is 240 participants. The study started on 2026-04-15. Estimated completion is 2027-05-30.
What interventions are being tested in trial NCT07447713?
The interventions under investigation include: Quantra System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07447713?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.